These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8292724)

  • 1. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium.
    Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pathway of coagulation on endothelial cells.
    Nawroth PP; Stern DM
    J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation.
    Rodgers GM; Kane WH; Pitas RE
    J Clin Invest; 1988 Jun; 81(6):1911-9. PubMed ID: 3164315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
    London F; Ahmad SS; Walsh PN
    Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
    Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
    J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T
    J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
    Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
    J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor as a regulator of intrinsic factor X activation.
    Koppelman SJ; Koedam JA; van Wijnen M; Stern DM; Nawroth PP; Sixma JJ; Bouma BN
    J Lab Clin Med; 1994 Apr; 123(4):585-93. PubMed ID: 8145007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
    Ran S; Downes A; Thorpe PE
    Cancer Res; 2002 Nov; 62(21):6132-40. PubMed ID: 12414638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an ideal amphipathic peptide as a procoagulant agent.
    Ganopolsky JG; Charbonneau S; Peng HT; Shek PN; Blostein MD
    Biochem J; 2008 Jun; 412(3):545-51. PubMed ID: 18336367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of factors IX and X by factor VIIa].
    Komiyama Y
    Rinsho Byori; 1992 Mar; Suppl 92():73-82. PubMed ID: 1583779
    [No Abstract]   [Full Text] [Related]  

  • 18. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
    Herbert J; Bono F; Herault J; Avril C; Dol F; Mares A; Schaeffer P
    J Clin Invest; 1998 Mar; 101(5):993-1000. PubMed ID: 9486969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
    van Rijn JL; Zwaal RF; Hemker HC; Rosing J
    Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms in blood coagulation.
    Davie EW; Kirby EP
    Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.